DarioHealth (NASDAQ:DRIO) Shares Pass Above 50-Day Moving Average – Time to Sell?

DarioHealth Corp. (NASDAQ:DRIO)’s share price crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.94 and traded as high as $1.00. DarioHealth shares last traded at $1.00, with a volume of 124,911 shares traded.

DarioHealth Stock Up 2.7 %

The stock has a market cap of $29.81 million, a price-to-earnings ratio of -0.59 and a beta of 1.48. The company has a current ratio of 2.26, a quick ratio of 1.96 and a debt-to-equity ratio of 0.34. The firm’s 50 day moving average is $0.94 and its two-hundred day moving average is $1.18.

DarioHealth (NASDAQ:DRIO) last announced its quarterly earnings data on Thursday, August 8th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.51) by $0.43. The business had revenue of $6.26 million for the quarter, compared to the consensus estimate of $7.57 million. DarioHealth had a negative net margin of 265.33% and a negative return on equity of 74.64%. On average, sell-side analysts predict that DarioHealth Corp. will post -1.21 EPS for the current year.

Institutional Investors Weigh In On DarioHealth

A number of hedge funds and other institutional investors have recently made changes to their positions in DRIO. Appian Way Asset Management LP boosted its stake in DarioHealth by 0.9% in the 1st quarter. Appian Way Asset Management LP now owns 1,334,142 shares of the company’s stock worth $2,041,000 after buying an additional 11,698 shares during the last quarter. Clarity Capital Partners LLC lifted its holdings in shares of DarioHealth by 20.1% during the 1st quarter. Clarity Capital Partners LLC now owns 204,758 shares of the company’s stock worth $313,000 after acquiring an additional 34,332 shares during the period. Finally, DLK Investment Management LLC lifted its holdings in shares of DarioHealth by 71.6% during the 3rd quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after acquiring an additional 41,943 shares during the period. Hedge funds and other institutional investors own 33.39% of the company’s stock.

DarioHealth Company Profile

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.